Fingerpaint Branding is proud to support pharmaceutical and life sciences companies around the globe with naming, visual identity, brand strategy, market research, and regulatory guidance. Here are a few of our most recent brand name and non-proprietary name approvals.

adrulipase alfa

alnuctamab

anumigilimab

anzurstobart

atamparib

avutometinib

bezetabart debotansine

betovumeline

bomedemstat

bomtabegagene bavoparvovec

brexucabtagene autoleucel

camizestrant

casirivimab/imdevimab

cavrotolimod

claseprubart

cliramitug

dimebutic acid

dordaviprone

dovramilast

duvakitug

eclitasertib

efzimfotase alfa

eganelisib

eladocagene exuparvovec

elegrobart

emvododstat

eragidomide

erepdekinra

fasedienol

feniralstat

fosgonimeton

frexalimab

gemlapodect

golcadomide

gorivitug

gozanertinib

idecabtagene vicleucel

imaradenant

imofinostat

inaxaplin

ispectamab tazide

itruvone

ixotatug vedotin

luveltamab tazevibulin

luvixasertib

mavrostobart

modakafusp alfa

nexiguran

ocifisertib

olisutrigine

onvansertib

oplunofusp

orpibestrant

ozisiran

palupiprant

pelecopan

pezadeftide

plixorafenib

pomlucabtagene autoleucel

produvofusp

refisolone

remlifanserin

rencofilstat

revumenib

rifaquizinone

rifasutenizol

rilunermin alfa

rovaleucel

senvesiran

sepiapterin

taniraleucel

tiomolibdic acid/tiomolibdate choline

tivinectide

trevotamig

trotabresib

tulisokibart

ultevursen

ulviprubart

unesbulin

upifitamab rilsodotin

utreloxastat

vanzacaftor

varokibart

veligrotug

vepdegestrant

vevoctadekin

vipivotide tetraxetan

voluloride

vortosiran

zelenectide pevedotin

zeltociclib

zemocimig

ziclumeran

zimislecel

To learn more about our creative services or speak with a branding expert, please contact us.

Author: Brittany Scott Last Updated: February 28, 2026